A detailed history of Ancora Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Ancora Advisors, LLC holds 269,566 shares of JNJ stock, worth $39.6 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares
269,566
Previous 283,194 4.81%
Holding current value
$39.6 Million
Previous $41.4 Million 5.54%
% of portfolio
1.08%
Previous 1.11%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $1.98 Million - $2.28 Million
-13,628 Reduced 4.81%
269,566 $43.7 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $286,883 - $313,508
1,987 Added 0.71%
283,194 $41.4 Million
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $2.9 Million - $3.05 Million
-18,715 Reduced 6.24%
281,207 $44.5 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $921,065 - $1.01 Million
-6,326 Reduced 2.07%
299,922 $47 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $1.27 Million - $1.42 Million
-8,153 Reduced 2.59%
306,248 $47.7 Million
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $645,800 - $695,004
4,184 Added 1.35%
314,401 $52 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $900,258 - $1.07 Million
5,960 Added 1.96%
310,217 $48.1 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $4.96 Million - $5.57 Million
30,959 Added 11.33%
304,257 $53.7 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $609,504 - $678,226
3,778 Added 1.4%
273,298 $44.6 Million
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $652,072 - $721,160
3,877 Added 1.46%
269,520 $47.8 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $312,642 - $355,049
1,977 Added 0.75%
265,643 $47.1 Million
Q1 2022

May 13, 2022

SELL
$158.14 - $179.59 $1.47 Million - $1.66 Million
-9,271 Reduced 3.4%
263,666 $43.3 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $870,557 - $965,914
5,583 Added 2.09%
272,937 $46.7 Million
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $1.48 Million - $1.64 Million
9,162 Added 3.55%
267,354 $43.2 Million
Q2 2021

Aug 13, 2021

SELL
$159.48 - $171.07 $872,993 - $936,437
-5,474 Reduced 2.08%
258,192 $42.5 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $971,994 - $1.08 Million
6,350 Added 2.47%
263,666 $43.3 Million
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $361,284 - $414,696
2,635 Added 1.03%
257,316 $40.5 Million
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $1.11 Million - $1.21 Million
7,877 Added 3.19%
254,681 $37.9 Million
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $381,535 - $460,620
2,962 Added 1.21%
246,804 $34.7 Million
Q1 2020

May 14, 2020

BUY
$111.14 - $153.99 $1.67 Million - $2.31 Million
15,033 Added 6.57%
243,842 $32 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $4.52 Million - $5.19 Million
35,463 Added 18.34%
228,809 $33.4 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $1.29 Million - $1.44 Million
10,155 Added 5.54%
193,346 $25 Million
Q2 2019

Aug 12, 2019

BUY
$131.15 - $144.24 $702,177 - $772,260
5,354 Added 3.01%
183,191 $25.5 Million
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $889,343 - $988,874
7,074 Added 4.14%
177,837 $24.9 Million
Q4 2018

Feb 15, 2019

BUY
$122.84 - $147.84 $665,424 - $800,849
5,417 Added 3.28%
170,763 $22 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $3.7 Million - $4.35 Million
30,418 Added 22.54%
165,346 $22.8 Million
Q2 2018

Aug 10, 2018

BUY
$119.4 - $131.76 $400,587 - $442,054
3,355 Added 2.55%
134,928 $16.4 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $2.42 Million - $2.87 Million
19,371 Added 17.26%
131,573 $16.9 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $383,556 - $419,801
2,923 Added 2.67%
112,202 $15.7 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $14.1 Million - $14.8 Million
109,279
109,279 $14.2 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $384B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.